Effectiveness of mouth rinses in reducing SARS-CoV-2 viral load in saliva. A narrative review
DOI:
https://doi.org/10.33448/rsd-v11i14.36655Keywords:
Mouth rinses; SARS-CoV-2; Viral load; Covid-19.Abstract
The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in oral fluids and the high generation of aerosols during dental procedures has led to the need to seek measures to control the transmission of this disease. The aim of this study is to present the available clinical evidence on the reduction of viral load and virucidal action of different oral antiseptics against SARS-CoV-2, and to propose their use as an effective preventive strategy prior to dental care. There is clinical evidence on the use of various mouth rinses at different concentrations and times for reduction of SARS-CoV-2 viral load in saliva. This literature review focuses on the available clinical evidence indicating the use of mouth rinses as an effective preventive measure in reducing the salivary SARS-CoV-2 viral load to avoid cross-transmission of Covid-19 disease during dental treatment. A literature search of available information from September 2020 to May 2022 was performed in PubMed, Google Scholar and Cochrane. Chlorhexidine 0.12%, iodopovidone 0.5-1% or cetylpyridinium chloride 0.04-0.075% reduce the viral load of SARS-CoV-2 in saliva and can be used to reduce the risk of SARS-CoV-2 transmission.
References
Almanza-Reyes, H., Moreno, S., Plascencia-López, I., Alvarado-Vera, M., Patrón-Romero, L., & Borrego, B. et al. (2021). Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: In vitro and in vivo. PLOS ONE, 16(8), e0256401. https://doi.org/10.1371/journal.pone.0256401
Carrouel, F., Valette, M., Gadea, E., Esparcieux, A., Illes, G., & Langlois, M. et al. (2021). Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial. Clinical Microbiology And Infection, 27(10), 1494-1501. https://doi.org/10.1016/j.cmi.2021.05.028
Chaudhary, P., Melkonyan, A., Meethil, A., Saraswat, S., Hall, D., & Cottle, J. et al. (2021). Estimating salivary carriage of severe acute respiratory syndrome coronavirus 2 in nonsymptomatic people and efficacy of mouthrinse in reducing viral load. The Journal Of The American Dental Association, 152(11), 903-908. https://doi.org/10.1016/j.adaj.2021.05.021
Costa, D., Brites, C., Vaz, S., Santana, D., Santos, J., & Cury, P. (2021). Chlorhexidine mouthwash reduces the salivary viral load of SARS‐CoV‐2: A randomized clinical trial. Oral Diseases. https://doi.org/10.1111/odi.14086
da Silva Santos, P., da Fonseca Orcina, B., Machado, R., Vilhena, F., da Costa Alves, L., & Zangrando, M. et al. (2021). Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-99013-5
Di Domênico, M., Cesca, H., Ponciano, T., dos Santos, R., Lenz, U., & Antunes, V. et al. (2021). Effectiveness of hydrogen peroxide as auxiliary treatment for hospitalized COVID-19 patients in Brazil: preliminary results of a randomized double-blind clinical trial. Epidemiology And Health, 43, e2021032. https://doi.org/10.4178/epih.e2021032
Eduardo, F., Corrêa, L., Heller, D., Daep, C., Benitez, C., & Malheiros, Z. et al. (2021). Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial. Heliyon, 7(6), e07346. https://doi.org/10.1016/j.heliyon.2021.e07346
Elzein, R., Abdel-Sater, F., Fakhreddine, S., Hanna, P., Feghali, R., Hamad, H., & Ayoub, F. (2021). In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial. Journal Of Evidence Based Dental Practice, 21(3), 101584. https://doi.org/10.1016/j.jebdp.2021.101584
Ferrer, M., Barrueco, Á., Martinez-Beneyto, Y., Mateos-Moreno, M., Ausina-Márquez, V., & García-Vázquez, E. et al. (2021). Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS-CoV-2. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-03461-y
Gottsauner, M., Michaelides, I., Schmidt, B., Scholz, K., Buchalla, W., & Widbiller, M. et al. (2020). A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2. Clinical Oral Investigations, 24(10), 3707-3713. https://doi.org/10.1007/s00784-020-03549-1
Guenezan, J., Garcia, M., Strasters, D., Jousselin, C., Lévêque, N., Frasca, D., & Mimoz, O. (2021). Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19. JAMA Otolaryngology–Head &Amp; Neck Surgery, 147(4), 400. https://doi.org/10.1001/jamaoto.2020.5490
Guimarães, T., Marques, B., Castro, M., Secco, D., Porto, L., & Tinoco, J. et al. (2022). Reducing the viral load of SARS‐CoV‐2 in the saliva of patients with COVID‐19. Oral Diseases. https://doi.org/10.1111/odi.14118
Gutiérrez-García, R., De La Cerda-Angeles, J., Cabrera-Licona, A., Delgado-Enciso, I., Mervitch-Sigal, N., & Paz-michel, B. (2021). Nasopharyngeal and oropharyngeal rinses with neutral electrolyzed water prevents COVID-19 in front-line health professionals: A randomized, open-label, controlled trial in a general hospital in Mexico City. Biomedical Reports, 16(2). https://doi.org/10.3892/br.2021.1494
Huang, Y., & Huang, J. (2021). Use of chlorhexidine to eradicate oropharyngeal SARS‐CoV‐2 in COVID‐19 patients. Journal Of Medical Virology, 93(7), 4370-4373. https://doi.org/10.1002/jmv.26954
Jayaraman, B., Rajan, G., Kannian, P., Lavanya, C., Ravichandran, K., & Kumarasamy, N. et al. (2021). Povidone iodine, hydrogen peroxide and chlorhexidine mouthwashes reduce SARS-CoV2 burden in whole mouth fluid and respiratory droplets. https://doi.org/10.1101/2021.02.25.21252488
Joshipura, K., Muñoz-Torres, F., Morou-Bermudez, E., & Patel, R. (2017). Over-the-counter mouthwash use and risk of pre-diabetes/diabetes. Nitric Oxide, 71, 14-20. https://doi.org/10.1016/j.niox.2017.09.004
Lim, N., Teng, O., Ng, C., Bao, L., Tambyah, P., Quek, A., & Seet, R. (2022). Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review. Annals Of Medicine, 54(1), 1488-1499. https://doi.org/10.1080/07853890.2022.2076902
Meister, T., Gottsauner, J., Schmidt, B., Heinen, N., Todt, D., & Audebert, F. et al. (2022). Mouthrinses against SARS-CoV-2 – High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial. Virus Research, 316, 198791. https://doi.org/10.1016/j.virusres.2022.198791
Mohamed, N., Baharom, N., Sulaiman, W., Rashid, Z., Ken, W., & Ali, U. et al. (2020). EARLY VIRAL CLEARANCE AMONG COVID-19 PATIENTS WHEN GARGLING WITH POVIDONE-IODINE AND ESSENTIAL OILS – A CLINICAL TRIAL. https://doi.org/10.1101/2020.09.07.20180448
Mukhtar, K., Qassim, S., Al Qahtani, S., Danjuma, M., Mohamedali, M., & Farhan, H. et al. (2020). A randomized trial on the regular use of potent mouthwash in COVID-19 treatment. https://doi.org/10.1101/2020.11.27.20234997
Muñoz-Basagoiti, J., Perez-Zsolt, D., León, R., Blanc, V., Raïch-Regué, D., & Cano-Sarabia, M. et al. (2021). Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro. Journal Of Dental Research, 100(11), 1265-1272. https://doi.org/10.1177/00220345211029269
Okamoto, N., Saito, A., Okabayashi, T., & Komine, A. (2022). Virucidal activity and mechanism of action of cetylpyridinium chloride against SARS-CoV-2. Journal Of Oral And Maxillofacial Surgery, Medicine, And Pathology, 34(6), 800-804. https://doi.org/10.1016/j.ajoms.2022.04.001
Pałka, Ł., Nowakowska-Toporowska, A., & Dalewski, B. (2022). Is Chlorhexidine in Dentistry an Ally or a Foe? A Narrative Review. Healthcare, 10(5), 764. https://doi.org/10.3390/healthcare10050764
Rizwana, N. (2013). The Role of Cetylpyridinium Chloride Mouthwash In The Treatment of Periodontitis. International Journal Of Pharmaceutical Science Invention, 2(12), 36-37. Retrieved 5 August 2022, from http://www.ijpsi.org/.
Seneviratne, C., Balan, P., Ko, K., Udawatte, N., Lai, D., & Ng, D. et al. (2020). Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore. Infection, 49(2), 305-311. https://doi.org/10.1007/s15010-020-01563-9
Serrano-Cumplido, A., Ruiz Garcia, A., Segura-Fragoso, A., Olmo-Quintana, V., Micó Pérez, R., Barquilla-García, A., & Morán-Bayón, A. (2021). Aplicación del valor umbral del número de ciclos (Ct) de PCR en la COVID-19. Medicina De Familia. SEMERGEN, 47(5), 337-341. https://doi.org/10.1016/j.semerg.2021.05.003
Sule, W., & Oluwayelu, D. (2020). Real-time RT-PCR for COVID-19 diagnosis: challenges and prospects. Pan African Medical Journal, 35. https://doi.org/10.11604/pamj.supp.2020.35.2.24258
Tadakamadla, S., Bharathwaj, V., Duraiswamy, P., Sforza, C., & Tartaglia, G. (2019). Clinical efficacy of a new cetylpyridinium chloride‐hyaluronic acid–based mouthrinse compared to chlorhexidine and placebo mouthrinses—A 21‐day randomized clinical trial. International Journal Of Dental Hygiene, 18(1), 116-123. https://doi.org/10.1111/idh.12413
Tribble, G., Angelov, N., Weltman, R., Wang, B., Eswaran, S., & Gay, I. et al. (2019). Frequency of Tongue Cleaning Impacts the Human Tongue Microbiome Composition and Enterosalivary Circulation of Nitrate. Frontiers In Cellular And Infection Microbiology, 9. https://doi.org/10.3389/fcimb.2019.00039
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Bryan David Torres Ramos; Boris Alejandro Eguiguren Samaniego; Jacinto Alvarado Cordero
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
